Find your next paid study

Jonsson Comprehensive Cancer CenterNCT07229339

~$75 – $2,000

Actual pay is set by the research site.

Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer

This is a correlative (lab-based) study aiming to identify protein markers in urine extracellular vesicles (EVs) that can be used to develop non-invasive molec…

Renal Cell CarcinomaClear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+2 more

Actual pay is set by the research site.

Mayo ClinicNCT07243067

Phase 1

A Phase 0/I/II Study of the Cyclin-Dependent Kinase(CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas

Background: NF1 is a genetic disease that causes tumors called atypical neurofibromas. These tumors, which arise from nerves, can cause serious medical proble…

Neurofibromatosis 1

National Cancer Institute (NCI)NCT04750928

~$150 – $2,700

Actual pay is set by the research site.

SPRINT: Sparking Potential, Revealing Infant Neurocognitive Traits

This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this…

Perinatal Brain InjuryHealthy Participants

University of Wisconsin, MadisonNCT07390136

Actual pay is set by the research site.

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Phase 2 Study of Combination Pirtobrutinib (LOXO-305) and Venetoclax in CLL Patients With Resistance to Covalent BTKi

This phase II trial tests how well pirtobrutinib (LOXO-305) and venetoclax works in treating patients with chronic lymphocytic leukemia (CLL) or small lymphocy…

~$75 – $3,000

Actual pay is set by the research site.

Kerry RogersNCT06466122

Breast CancerResidual DiseaseTriple Negative Breast Cancer (TNBC)+1 more

PREDICT-RD: Postoperative Molecular Residual Disease by ctDNA Surveillance in TNBC With Residual Disease

This is a Phase II, interventional, prospective, single-arm, multi-center study that will enroll patients with stage II/III triple negative breast cancer (TNBC…

UNC Lineberger Comprehensive Cancer CenterNCT07069595

~$75 – $2,000

Actual pay is set by the research site.

Assessment of Biomarker-Guided Calcineurin Inhibitor (CNI) Substitution In Kidney Transplantation (RTB-015)

800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/D…

Kidney Transplant

National Institute of Allergy and Infectious Diseases (NIAID)NCT05917522

~$75 – $1,800

Actual pay is set by the research site.

Observational

Rehabilitation of Reading Deficits in Subacute Stroke Using Functional Magnetic Resonance Imaging (fMRI) Neurofeedback and Motor Imagery

The overall goal of this project is to advance a biologically-based approach to treatment of reading disorders after stroke, which will expand the limits of co…

StrokeDyslexia, Acquired

Kessler FoundationNCT04875936

Actual pay is set by the research site.

Observational

Talking About Cannabis: Developing an Intervention for Family Members of Young Adults With FEP to Support Reduced Cannabis Use

The objectives of this research is to (1) create a family intervention and provider manual to train family members of young people with psychosis (YP-P) who ar…

Caregiver BurdenCannabis UseExpressed Emotion+1 more

University of WashingtonNCT06961877

Actual pay is set by the research site.

Penn Sjögren's International Clinical Collaborative Alliance (SICCA) Follow-up Study

This study will involve the collection of follow-up data for patients who previously participated in the Sjogren's International Clinical Collaborative Allianc…

Dry EyeSjogren's Syndrome

University of PennsylvaniaNCT05056012

Actual pay is set by the research site.

Phase 1

A Phase 1 Study Of LNK001 (Dual ENPP3/CAIX AND-gate CAR T Cell Therapy) In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). The goal of Part 1 is to find the recommended dose of…

Clear Cell Renal Cell Carcinoma

M.D. Anderson Cancer CenterNCT07564232

~$150 – $3,000

Actual pay is set by the research site.

Non Small Cell Lung Cancer

A Phase 2 Study of Circulating Tumor DNA to Predict Response to Neoadjuvant Treatment and De-escalation Adjuvant Immunotherapy in Early-Stage NSCLC (DNA-PREDICT)

The purpose of this study is to determine if a blood test called circulating tumor DNA (ctDNA) can be used to predict how well patients will respond to treatme…